CGT Global Blog

Featured Post

Partnership Newsflash

By pboyd | September 21, 2023 | Comments Off on Partnership Newsflash
CGT Global and Octomera have entered into an agreement

In an exciting development in the world of biotechnology, CGT Global and Octomera have entered into a groundbreaking agreement aimed at expanding cell and gene therapy development and patient access across the United States. This partnership…

Read More

Meet our Laboratory Team

By pboyd | September 15, 2023 | Comments Off on Meet our Laboratory Team
CGT Global: Peel into our laboratory's expertise

  CGT Global is thrilled to introduce you to the incredible members of our laboratory team who make the magic happen every day. Bryan: The Fearless Leader With an analytical mind and a passion for innovation,…

Read More

Webinar: Access to Cell and Gene Therapies

By pboyd | August 18, 2023 | Comments Off on Webinar: Access to Cell and Gene Therapies
Thumbnail image - Webinar playback

Addressing Disparities in Access to Cell and Gene Therapies We are thrilled to share the fantastic outcome of our recent webinar, ” Addressing Disparities in Access to Cell and Gene Therapies.” The engagement and insightful discussions…

Read More

New Discovery of 60 Genetic Mutations

By CGT Global | April 21, 2023 | Comments Off on New Discovery of 60 Genetic Mutations

Holy DNA! Scientists have just uncovered 60 new genetic diseases that hadn’t been discovered before! It’s like finding a whole bunch of new Pokémon, except these new discoveries are going to have a real impact on the lives of thousands of families.

So here’s the scoop: these scientists analyzed the DNA of over 13,500 people who had previously been struggling with undiagnosed developmental delays or intellectual disabilities. They used a fancy technique called exome sequencing, which basically reads the important parts of your DNA that make proteins. By comparing the DNA of these individuals to a reference genome, the researchers were able to spot mutations or variations that were unique to the affected individuals.

Read More